Oncolytic Virotherapy (OV) is an emerging modality for cancer that uses genetically modified viruses that specifically replicate in and destroy cancer cells while assisting the immune system to generate an anti-tumor immunity. However, OV is severely limited due to the body’s immune response against viruses causing rapid clearance.

Our multiple award winning patented nanoencapsulation and virus coating technology generates a nanolayer around a virus surface without harming the virus or modifying its genetically-engineered anti-cancer weapons.